Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2026-02-22 @ 6:46 PM
Study NCT ID:
NCT06680258
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-09-03
First Post:
2024-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy
Sponsor:
Tempest Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-12
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-07
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-04
First Submit QC Date:
None
Study First Post Date:
2024-11-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-02
Last Update Post Date:
2025-09-03
Last Update Post Date Type:
ESTIMATED